Synlogic (NASDAQ:SYBX) Shares Pass Below Fifty Day Moving Average – Here’s What Happened

Synlogic, Inc. (NASDAQ:SYBX)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.67 and traded as low as $1.59. Synlogic shares last traded at $1.59, with a volume of 11,810 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Synlogic in a report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Synlogic currently has an average rating of “Sell”.

Synlogic Stock Performance

The firm’s 50 day simple moving average is $1.67 and its 200-day simple moving average is $1.43. The company has a market capitalization of $18.60 million, a price-to-earnings ratio of -19.88 and a beta of 0.55.

About Synlogic

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.